Skip To Main Content
Stephen Liu on Muck Rack

Stephen Liu

West
As seen in: Markets Insider, Nature, MDPI, International Business Times (U.S.), Medscape, GlobeNewswire, KTLA-TV (Los Angeles, CA), Morningstar, KDVR-TV (Denver, CO), StreetInsider and
privycircle.com privycircle.eth privy.net privy.eth privy.sol privy/

Get in touch with Stephen

Contact Stephen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma

|
By Karam Ashouri, Fan Sun, Harris B. Krause, Andrew Elliott, Stephen Liu, Patrick C. Ma, Balazs Halmos, Gutian Xiao, Ari VanderWalde, Jorge Nieva, Zhaoxia Qu
| Nature Verified
Abstract While PDZ-LIM domain-containing protein (PDLIM2) suppresses lung cancer, its clinical significance and therapeutic potential remain to be fully explored. Next-generation sequencing and immunohistochemistry of programmed death ligand 1 (PD-L1) were performed on lung adenocarcinoma (LUAD) tissues from 15,765 patients. PDLIM2 gene therapy was tested in syngeneic LUAD mouse models using intravenous nano-complexed plasmid DNA, alone or with chemoimmunotherapy.
Open in Who Shared Issue with article?

Trends in Emergency Department Visits Involving Cannabis Hyperemesis Syndrome Identified Using a New Diagnosis Code — United States, January 2023–May 2026

|
By Alana M. Vivolo-Kantor, Stephen Liu, Lauren J Tanz
| A Cup of Health with CDC
Discussion The proportion of CHS-involved ED visits remained steady during January 2023–September 2025 until the introduction of a new diagnosis code for CHS in October 2025, after which a marked increase occurred. The abruptness and sustained magnitude of the increase likely reflects, at least in part, improved clinical recognition and coding of CHS rather than a true and immediate rise in incidence.
Open in Who Shared Issue with article?

SourceBench: Can AI Answers Reference Quality Web Sources?

|
By Stephen Liu, Yuheng Li, Simran Malik
| arXiv
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Open in Who Shared View Duplicates (472) Issue with article?
See all 115 licensed articles (232 Total)